Literature DB >> 2180015

The treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).

D M Komp1.   

Abstract

The available information on treatment of sinus histiocytosis with massive lymphadenopathy (SHML) was reviewed. Treatment is not necessary in most instances, but some patients may require surgery, radiation therapy, and/or chemotherapy because of severe disease manifestations. An ideal treatment has yet to be identified. Of the various chemotherapeutic regimens that have been tried so far, a combination of vinca alkaloid, alkylating agent, and corticosteroid appears to be the most effective.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180015

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  34 in total

1.  Rosai-Dorfman disease presenting with isolated bilateral orbital masses: report of two cases.

Authors:  E Wang; Y Anzai; A Paulino; J Wong
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

2.  Primary intracerebral rosai-dorfman disease: a case report.

Authors:  S Natarajan; K D Post; J Strauchen; S Morgello
Journal:  J Neurooncol       Date:  2000-03       Impact factor: 4.130

3.  Sinus histiocytosis with massive lymphadenopathy: complicated by autoimmune hemolytic anemia.

Authors:  Penukonda Sasi Kiran; Vasantha Prema Sowdi; Sumanth B Shetty; U Venugopal; S Parameshwariah; Edwin Dias; C S Kamala
Journal:  Indian J Pediatr       Date:  2003-09       Impact factor: 1.967

4.  Orthopaedic case of the month: a 50-year-old woman with persistent knee pain.

Authors:  Brian E Walczak; Dorothy M Halperin; Rabei W Bdeir; Ronald B Irwin
Journal:  Clin Orthop Relat Res       Date:  2011-09-20       Impact factor: 4.176

5.  Sinus histiocytosis with massive lymphadenopathy.

Authors:  D K Stones; C Havenga
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

Review 6.  Extranodal Rosai-Dorfman disease of bone, subcutaneous tissue and paranasal sinus mucosa with a review of its pathogenesis.

Authors:  Angela J Yoon; May Parisien; Frieda Feldman; Francis Young-In Lee
Journal:  Skeletal Radiol       Date:  2005-08-11       Impact factor: 2.199

7.  Rosai-Dorfman disease manifesting as intracranial and intraorbital lesion.

Authors:  Archana Hinduja; L Giselle Aguilar; Thomas Steineke; David Nochlin; Joseph C Landolfi
Journal:  J Neurooncol       Date:  2008-11-20       Impact factor: 4.130

8.  Radiotherapy for steroid-resistant laryngeal Rosai-Dorfman disease.

Authors:  D Toguri; A V Louie; K Rizkalla; J Franklin; G Rodrigues; V Venkatesan
Journal:  Curr Oncol       Date:  2011-06       Impact factor: 3.677

9.  Report of isolated epidural extra-nodal Rosai-Dorfman disease of cervicothoracic spine.

Authors:  Apoorv Kumar; Balamurugan Thirugnanam; Shaffaf Abdul Kareem; S P Ajay Kumar; S Vidyadhara
Journal:  Spinal Cord Ser Cases       Date:  2020-08-27

10.  A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease?

Authors:  Madhu P Menon; Moses O Evbuomwan; Juan Rosai; Elaine S Jaffe; Stefania Pittaluga
Journal:  Histopathology       Date:  2013-11-12       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.